<?xml version="1.0" encoding="UTF-8"?>
<boxed-text id="pntd.0006919.box002" position="float" orientation="portrait">
 <sec id="sec011">
  <title>Top five papers</title>
  <p>Venturi G, Di Luca M, Fortuna C, Remoli ME, Riccardo F, Severini F, et al. Detection of a chikungunya outbreak in Central Italy, August to September 2017. Euro Surveill. 2017;22(39). doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00646" xmlns:xlink="http://www.w3.org/1999/xlink">10.2807/1560-7917.ES.2017.22.39.17-00646</ext-link>. PubMed PMID: 29019306; PubMed Central PMCID: PMCPMC5709953.
  </p>
  <p>Ramsauer K, Schwameis M, Firbas C, Mullner M, Putnak RJ, Thomas SJ, et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The Lancet infectious diseases. 2015. Epub 2015/03/06. doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(15)70043-5" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S1473-3099(15)70043-5</ext-link>. PubMed PMID: 25739878.
  </p>
  <p>Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 2014. Epub 2014/08/19. doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(14)61185-5" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S0140-6736(14)61185-5</ext-link>. PubMed PMID: 25132507.
  </p>
  <p>Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231–9. Epub 2015/03/26. doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMra1406035" xmlns:xlink="http://www.w3.org/1999/xlink">10.1056/NEJMra1406035</ext-link>. PubMed PMID: 25806915.
  </p>
  <p>Yang S, Fink D, Hulse A, Pratt RD. Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus. Vaccine. 2017;35(37):4851–8. doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2017.07.065" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.vaccine.2017.07.065</ext-link>. PubMed PMID: 28760614.
  </p>
 </sec>
</boxed-text>
